Kelli M. Jones

发表

Acute Neurotoxicity of Antisense Oligonucleotides After Intracerebroventricular Injection Into Mouse Brain Can Be Predicted from Sequence Features

A. Cacace, R. Olson, Amy Easton, 2022, Nucleic acid therapeutics.

Identification and characterization of a MAPT-targeting locked nucleic acid antisense oligonucleotide therapeutic for tauopathies

A. Cacace, J. Macor, Tai-Hsien Ou Yang, 2022, Molecular therapy. Nucleic acids.

Discovery and Preclinical Evaluation of BMS-955829, a Potent Positive Allosteric Modulator of mGluR5.

J. Macor, Amy Easton, Anand Balakrishnan, 2016, ACS medicinal chemistry letters.

The Novel, Nicotinic Alpha7 Receptor Partial Agonist, BMS-933043, Improves Cognition and Sensory Processing in Preclinical Models of Schizophrenia

J. Macor, Yulia Benitex, D. Post‐Munson, 2016, PloS one.

Effect of alpha7 nicotinic acetylcholine receptor agonists on attentional set-shifting impairment in rats

I. Mcdonald, R. Olson, L. Bristow, 2013, Psychopharmacology.

Effects of BMS‐902483, an &agr;7 nicotinic acetylcholine receptor partial agonist, on cognition and sensory gating in relation to receptor occupancy in rodents

Y. Asaka, J. Macor, J. Herrington, 2017, European journal of pharmacology.

P2-346: PGP efflux and other factors limit brain Aβ reduction by BACE1 inhibitors in mice

J. Macor, J. Marcinkeviciene, M. Ford, 2008, Alzheimer's & Dementia.

Donepezil primarily attenuates scopolamine-induced deficits in psychomotor function, with moderate effects on simple conditioning and attention, and small effects on working memory and spatial mapping

V. Gribkoff, J. Leet, M. D. Lindner, 2006, Psychopharmacology.

Effect of alpha7 nicotinic acetylcholine receptor agonists on attentional set-shifting impairment in rats

I. Mcdonald, R. Olson, L. Bristow, 2014, Psychopharmacology.